latest news releases from the newsroom
Enea Signs Frame Agreement with Trimble
TABY, Sweden, Jan. 08, 2004 (PRIMEZONE) -- Enea Embedded Technology AB has concluded a frame agreement with Trimble AB starting 2004. The agreement applies to consultant services for the development of software in embedded real-time systems. Trimble is a world leader in the development and marketing of instruments for measuring position and uses technologies such as GPS, lasers and optics.
Akzo Nobel to Transfer Antithrombotic Arixtra to Sanofi-Synthelabo
ARNHEM, The Netherlands, Jan. 08, 2004 (PRIMEZONE) -- Akzo Nobel's human healthcare business Organon and Sanofi-Synthelabo have announced that they have agreed in principle to revise the terms of their collaboration on antithrombotic Arixtra(r) and certain other oligosaccharides, such as idraparinux (SanOrg 34006). Pursuant to this deal, Organon will transfer to Sanofi- Synthelabo its remaining rights for Arixtra and development obligations for Arixtra and other oligosaccharides in exchange for revenues based on future sales.
XsunX Marks Launch of Commercialization Drive
ALISO VIEJO, Calif., Jan. 8, 2004 (PRIMEZONE) -- XsunX (OTCBB:XSNX), announced today that in its drive toward the commercialization and licensing of its breakthrough technology to produce transparent solar electric glass and films, the company has launched its commercial development efforts. The Company is now preparing to bring the opportunity for an entirely new group of solar electric products to the forefront of the Building Integrated Photovoltaics "BIPV" industry.
Notice of Extraordinary General Meeting of Skandia
STOCKHOLM, Sweden, Jan. 08, 2004 (PRIMEZONE) -- Shareholders of SKANDIA INSURANCE COMPANY LTD (publ) ("the Company") are hereby summoned to an Extraordinary General Meeting on Wednesday, 28 January 2004, at 4.30 p.m. (Swedish time). Location: Globe Arena, Annex, Arenatorget, Entrance 2, Stockholm, Sweden.
Celltech Group plc
Celltech Achieves Further Milestone In Osteoporosis Collaboration With Amgen
SLOUGH, U.K., Jan. 8, 2004 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) today announces the achievement of a further milestone in its agreement with Amgen Inc. for the research, development and global commercialisation of novel treatments for osteoporosis using Celltech's proprietary antibody fragment technology, which aims to identify antibody fragments against sclerostin, a protein discovered by Celltech. Sclerostin is involved in the regulation of bone deposition, and it is believed that by inhibiting this protein, bone loss in osteoporosis patients may be reversed.
Spector Roseman Kodroff & Willis, P.C.
Spector, Roseman & Kodroff, P.C. Announces the Filing of a Class Action Suit Against Massachusetts Financial Services Company, MFS Investment Management and the MFS Family of Funds -- MFRFX, MIGFX, MSFRX, MEIAX
PHILADELPHIA, Jan. 7, 2004 (PRIMEZONE) -- The law firm of Spector, Roseman & Kodroff, P.C. announces that a class action lawsuit was commenced in the United States District Court for the District of Massachusetts on behalf of purchasers, redeemers and holders of shares of Massachusetts Financial Services Company ("MFS Mutual Funds" or the "Company"), a subsidiary of Sun Life Financial, Inc. (NYSE:SLF) between December 15, 1998 through December 8, 2003, inclusive (the "Class Period").